Shanghai Allist Pharmaceuticals Co. Ltd. A - Asset Resilience Ratio

Latest as of September 2025: 30.29%

Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has an Asset Resilience Ratio of 30.29% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Shanghai Allist Pharmaceuticals Co. Ltd. total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥2.20 Billion

≈ $321.80 Million USD Cash + Short-term Investments

Total Assets

CN¥7.26 Billion

≈ $1.06 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2019–2024)

This chart shows how Shanghai Allist Pharmaceuticals Co. Ltd. A's Asset Resilience Ratio has changed over time. See what is Shanghai Allist Pharmaceuticals Co. Ltd.'s book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Shanghai Allist Pharmaceuticals Co. Ltd. A's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Shanghai Allist Pharmaceuticals Co. Ltd..

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥2.20 Billion	30.29%
Total Liquid Assets	CN¥2.20 Billion	30.29%

Asset Resilience Insights

Very High Liquidity: Shanghai Allist Pharmaceuticals Co. Ltd. A maintains exceptional liquid asset reserves at 30.29% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Shanghai Allist Pharmaceuticals Co. Ltd. A Industry Peers by Asset Resilience Ratio

Compare Shanghai Allist Pharmaceuticals Co. Ltd. A's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Royalty Pharma Plc NASDAQ:RPRX	Biotechnology	0.10%
Tubize-Fin BR:TUB	Biotechnology	0.05%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	4.52%
Shanghai Junshi Biosciences Co Ltd SHG:688180	Biotechnology	4.28%
Spyre Therapeutics Inc. NASDAQ:SYRE	Biotechnology	83.49%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	41.74%
Ascletis Pharma Inc F:2VJ	Biotechnology	10.83%

Annual Asset Resilience Ratio for Shanghai Allist Pharmaceuticals Co. Ltd. A (2019–2024)

The table below shows the annual Asset Resilience Ratio data for Shanghai Allist Pharmaceuticals Co. Ltd. A.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	46.64%	CN¥2.76 Billion ≈ $403.77 Million	CN¥5.92 Billion ≈ $865.72 Million	+37.05pp
2023-12-31	9.59%	CN¥419.60 Million ≈ $61.40 Million	CN¥4.38 Billion ≈ $640.42 Million	-35.93pp
2022-12-31	45.52%	CN¥1.57 Billion ≈ $229.27 Million	CN¥3.44 Billion ≈ $503.70 Million	-6.38pp
2021-12-31	51.90%	CN¥1.62 Billion ≈ $237.74 Million	CN¥3.13 Billion ≈ $458.06 Million	-22.60pp
2020-12-31	74.50%	CN¥2.23 Billion ≈ $325.66 Million	CN¥2.99 Billion ≈ $437.10 Million	+32.77pp
2019-12-31	41.73%	CN¥554.40 Million ≈ $81.13 Million	CN¥1.33 Billion ≈ $194.39 Million	--

pp = percentage points

About Shanghai Allist Pharmaceuticals Co. Ltd. A

SHG:688578 China Biotechnology

Market Cap

$6.29 Billion

CN¥42.99 Billion CNY

Market Cap Rank

#3103 Global

#439 in China

Share Price

CN¥95.53

Change (1 day)

+3.16%

52-Week Range

CN¥83.40 - CN¥118.30

All Time High

CN¥118.30